REZYLNEC Trademark
Trademark Overview
On Monday, May 6, 2024, a trademark application was filed for REZYLNEC with the United States Patent and Trademark Office. The USPTO has given the REZYLNEC trademark a serial number of 79398410. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Thursday, November 28, 2024. This trademark is owned by Boehringer Ingelheim International GmbH. The REZYLNEC trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the alimentary tract and metabolism; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the blood and blood forming organs; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system and respiratory system; pharmaceutical preparations for the prevention and treatment of dermatological diseases and disorders, damaged skin and tissues; pharmaceutical preparations for the prevention and treatment of inflammation and inflammatory diseases and disorders; pharmaceutical preparations for the prevention and treatment of ophthalmological diseases and disorders; pharmaceutical preparations for the treatment and prevention of hormonal diseases and disorders; pharmaceutical preparations for the treatment and prevention ...
General Information
| Serial Number | 79398410 |
| Word Mark | REZYLNEC |
| Filing Date | Monday, May 6, 2024 |
| Status | 681 - PUBLICATION/ISSUE REVIEW COMPLETE |
| Status Date | Thursday, November 28, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, December 17, 2024 |
Trademark Statements
| Goods and Services | Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the alimentary tract and metabolism; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the blood and blood forming organs; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system and respiratory system; pharmaceutical preparations for the prevention and treatment of dermatological diseases and disorders, damaged skin and tissues; pharmaceutical preparations for the prevention and treatment of inflammation and inflammatory diseases and disorders; pharmaceutical preparations for the prevention and treatment of ophthalmological diseases and disorders; pharmaceutical preparations for the treatment and prevention of hormonal diseases and disorders; pharmaceutical preparations for the treatment and prevention of infectious diseases and disorders and viral infections; pharmaceutical preparations for the prevention and treatment of oncological and auto-immune diseases and disorders; pharmaceutical preparations, namely, cell based immune therapeutics for treatment of cancer, for treatment of immunological diseases, and treatment of infectious diseases. |
| Translation of Words in Mark | The wording REZYLNEC has no meaning in a foreign language. |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, July 23, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Boehringer Ingelheim International GmbH |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | DE |
Trademark Events
| Event Date | Event Description |
| Thursday, June 27, 2024 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Tuesday, July 23, 2024 | LIMITATION FROM ORIGINAL APPLICATION ENTERED |
| Wednesday, July 24, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, July 24, 2024 | APPLICATION FILING RECEIPT MAILED |
| Monday, October 28, 2024 | ASSIGNED TO EXAMINER |
| Tuesday, November 5, 2024 | NON-FINAL ACTION WRITTEN |
| Wednesday, November 6, 2024 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Tuesday, November 12, 2024 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Tuesday, November 12, 2024 | REFUSAL PROCESSED BY MPU |
| Friday, November 22, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, November 22, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, November 22, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, November 25, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
